DanCann Pharma A/S announces that the Company has appointed Peter Søndergaard as new Chief Financial Officer ('CFO'). Peter Søndergaard, who holds a Master of Science in Strategy and Management, has more than 15 years of experience from C-level employment in production and sales companies. At DanCann Pharma, Peter Søndergaard will lead the finance function in the growing organization, which consists of DanCann Pharma A/S and the subsidiary CannGros ApS.

He will be responsible for developing and implementing relevant financial management tools adapted to the individual business areas in collaboration with the executive management team, of which he will be a part together with CEO Jeppe Krog Rasmussen, COO Sarah Mai Holm and CEO in the subsidiary CannGros, Louise Conradsen. Peter Søndergaard has joined the Company from the beginning of January together with two more new colleagues. DanCann Pharma has 18 employees from January 2023.